Erythropoietin alfa
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Erythropoietin alfa, covering 2009-06-11 to 2025-07-16. Get the full timeline:
Most recent: Clinical Trial Update: ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients [Phase 3]